CCR10表达是黏膜趋化因子CCL28作为HIV-1包膜DNA疫苗佐剂活性所必需的
研究假设编码CCL28的质粒DNA与HIV-1包膜抗原DNA疫苗共免疫可增强黏膜抗HIV IgA应答。小鼠共免疫pCCL28与pEnvA/C后,粪便提取物中HIV特异性IgA显著增加,血清抗HIV IgG也显著增加,且这些应答依赖于CCR10表达,在CCR10缺陷动物中消失。
要点
- pCCL28与pEnvA/C共免疫小鼠粪便提取物HIV特异性IgA显著增加。
- 共免疫还诱导血清抗HIV IgG显著增加,而单独pEnvA/C组无此效果。
- 抗体应答在CCR10缺陷动物中消失,表明依赖CCR10表达。
核心结论
- CCL28给药可在全身和黏膜表面增强抗原特异性体液应答。
研究设计与样本
- 小鼠免疫实验,比较pCCL28与pEnvA/C共免疫组与单独pEnvA/C组的抗体应答,并在CCR10缺陷动物中验证依赖性。
主要发现
- 与单独接受pEnvA/C的小鼠相比,接受pCCL28和pEnvA/C的动物粪便提取物中HIV特异性IgA显著增加。
- 与单独接受pEnvA/C的小鼠相比,CCL28共免疫诱导小鼠血清抗HIV IgG显著增加。
- 这些强烈的抗体应答与生发中心B细胞频率变化无关,但依赖于CCR10表达,在CCR10缺陷动物中应答消失。
- 与单独接受pEnvA/C的动物相比,CCL28免疫导致接种动物小肠和派尔集合淋巴结中HIV特异性CCR10+和CCR10+IgA+B细胞频率增加。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An effective prophylactic vaccine targeting HIV must induce a robust humoral response and must direct the bulk of this response to the mucosa-the primary site of HIV transmission. The chemokine, CCL28, is secreted by epithelial cells at mucosal surfaces and recruits' cells expressing its receptor CCR10. CCR10 is predominantly expressed by IgA + ASCs. We hypothesized that co-immunization with plasmid DNA encoding consensus envelope antigens with plasmid-encoded CCL28 would enhance anti-HIV IgA responses at mucosal surfaces. Indeed, animals receiving pCCL28 and pEnvA/C had significantly increased HIV-specific IgA in fecal extract. Surprisingly, CCL28 co-immunization induced a significant increase in anti-HIV IgG in the serum in mice compared to those receiving pEnvA/C alone. These robust antibody responses were not associated with changes in the frequency of germinal center B cells but depended upon the expression of CCR10, as these responses we abolished in CCR10-deficient animals. Finally, immunization with CCL28 led to increased frequencies in HIV-specific CCR10 + and CCR10 + IgA + B cells in the small intestine and Peyer's patches of vaccinated animals as compared to those receiving pEnvA/C alone. These data indicate that CCL28 administration can enhance antigen-specific humoral responses systemically and at mucosal surfaces.
引用
- Gary EN, Kathuria N, Makurumidze G, et al. CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine. Vaccine. 2020. PMID: 32057572. doi:10.1016/j.vaccine.2020.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。